Srs Capital Advisors, Inc. Procept Bio Robotics Corp Transaction History
Srs Capital Advisors, Inc.
- $1.07 Billion
- Q3 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 43 shares of PRCT stock, worth $3,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 43
-0.0%
Holding current value
$3,599
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$405 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$292 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$128 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$104 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$98.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.73B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...